FDA inspection
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.: FDA inspection ending Sep 16, 2021
FDA inspection 1153206 · No Action Indicated (NAI) · Shenzhen
Key facts
| Inspection ID | 1153206 |
|---|---|
| Firm | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. |
| FEI number | 3014772595 |
| Address | Building Ii, No. 1 Rongtian South; Kengzi Sub-District |
| City | Shenzhen |
| Fiscal year | 2021 |
| Inspection end date | Sep 16, 2021 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data